Logro de las metas de colesterol LDL en pacientes con enfermedad coronaria aterosclerótica establecida

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459-44. Roth, 2017, Global Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015, J Am Coll Cardiol., 70, 1, 10.1016/j.jacc.2017.04.052 Joseph, 2017, Reducing the Global Burden of Cardiovascular Disease, Part 1: The Epidemiology and Risk Factors. Circ Res., 121, 677 Fernando, 2014, Cardiovascular disease in Latin America: the growing epidemic, Prog Cardiovasc Dis., 57, 262, 10.1016/j.pcad.2014.07.007 Leong, 2017, Reducing the Global Burden of Cardiovascular Disease Part 2: Prevention and Treatment of Cardiovascular Disease, Circ Res., 121, 695, 10.1161/CIRCRESAHA.117.311849 Catapano, 2017, 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias, Rev Esp Cardiol (Engl Ed)., 70, 115 Grundy, 2002, Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report, Circulation., 106, 3143, 10.1161/circ.106.25.3143 Grundy, 2014, An International Atherosclerosis Society position paper: global recommendations for the management of dyslipidemia: executive summary, Atherosclerosis., 232, 410, 10.1016/j.atherosclerosis.2013.11.031 Rabar, 2014, Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance, BMJ., 349, 10.1136/bmj.g4356 Weng, 2010, A systematic review and meta-analysis on the therapeutic equivalence of statins, J Clin Pharm Ther., 35, 139, 10.1111/j.1365-2710.2009.01085.x Katsiki, 2018, Statin loading in cardiovascular surgery: never too early to treat, Curr Opin Cardiol., 33, 436, 10.1097/HCO.0000000000000519 Grundy, 2018, AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, J Am Coll Cardiol., 73, 285, 10.1016/j.jacc.2018.11.003 Múñoz, 2015, Guía de práctica clínica para la prevención, detección temprana, diagnóstico, tratamiento y seguimiento de las dislipidemias: tratamiento farmacológico con estatinas, Rev Colomb Cardiol., 22, 14 Jacobson, 2015, National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2, J Clin Lipidol., 9 Garber, 2016, Consensus statement by the american association of clinical endocrinologists and american college of endocrinology on the comprehensive type 2 diabetes management algorithm--2016 Executive summary, Endocr Pract., 22, 84, 10.4158/EP151126.CS Chamberlain, 2018, Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018, Ann Intern Med., 168, 640, 10.7326/M18-0222 Khatib, 2016, Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data, Lancet., 387, 61, 10.1016/S0140-6736(15)00469-9 Merchán, 2011, ¿Se están alcanzando las metas en el perfil lipídico de personas con enfermedad coronaria previa?, Rev Colomb Cardiol., 18, 262 Cannon, 2017, Simulation of lipid-lowering therapy intensification in a population with atherosclerotic cardiovascular disease, JAMA Cardiol., 2, 959, 10.1001/jamacardio.2017.2289